Cantai Therapeutics
Philadelpia, US · Founded 2023 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
JB
Joshua BrandtDirector
EA
Errik AndersonExecutive Officer, Director
RL
Ross LeimbergExecutive Officer, Director
GV
Geeta VemuriExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$3MraisedJan 2026 · 3 investors · BiotechnologyRule 506(b)
▶$3MraisedJan 2026 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ross LeimbergExecutive Officer, Director
- Errik B. AndersonExecutive Officer
- Getta VemuriExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$550KraisedJul 2025 · 3 investors · BiotechnologyRule 506(b)
▶$550KraisedJul 2025 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joshua BrandtDirector
- Errik AndersonExecutive Officer, Director
- Ross LeimbergExecutive Officer, Director
- Geeta VemuriExecutive Officer, Director
- Offering amount
- $1.1M
- Amount sold
- $550K
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$700KraisedNov 2023 · 3 investors · BiotechnologyRule 506(b)
▶$700KraisedNov 2023 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Geeta VemuriExecutive Officer, Director
- Errik AndersonExecutive Officer, Director
- Ross LeimbergExecutive Officer
- Joshua BrandtExecutive Officer
- Offering amount
- $3M
- Amount sold
- $700K
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.